IPSC - Century Therapeutics GAAP EPS of -$0.56 revenue of $0.09M August, 09 2023 12:25 PM Century Therapeutics Inc. 2023-08-09 12:25:54 ET Century Therapeutics press release ( NASDAQ: IPSC ): Q2 GAAP EPS of -$0.56. Revenue of $0.09M. For further details see: Century Therapeutics GAAP EPS of -$0.56, revenue of $0.09M